Log In
updated 10:20 AM UTC, Dec 13, 2023

Pfizer, BioNTech COVID-19 Vaccine Is More Than 90% Effective

Unic Press UK: A drug manufacturing leviathan Pfizer and its collaborator, BioNTech, have announced positive efficacy results from a Phase 3 study of a potential COVID-19 vaccine.

In a statement Monday, Pfizer’s chief executive officer, Albert Bourla, said: “The vaccine candidate was found to be more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy analysis.”

The results so far have demonstrated that the group’s mRNA-based vaccine helps to prevent COVID-19 in the majority of people who receive it, Pfizer added.

President Donald Trump, who had given a hint of the research breakthrough prior to the news, believes that the announcement Monday of a vaccine success was deliberately delayed by the U.S. Food and Drug Administration in collaboration with the Democrats.

Tagged under

Leave a Reply